6-Chloropurine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside structure
|
Common Name | 6-Chloropurine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside | ||
|---|---|---|---|---|
| CAS Number | 135473-15-3 | Molecular Weight | 496.87 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 665.6±65.0 °C at 760 mmHg | |
| Molecular Formula | C24H18ClFN4O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 356.4±34.3 °C | |
Use of 6-Chloropurine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside6-Chloro-9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 6-Chloro-9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine |
|---|---|
| Synonym | More Synonyms |
| Description | 6-Chloro-9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 665.6±65.0 °C at 760 mmHg |
| Molecular Formula | C24H18ClFN4O5 |
| Molecular Weight | 496.87 |
| Flash Point | 356.4±34.3 °C |
| Exact Mass | 496.094971 |
| LogP | 5.11 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.682 |
| Storage condition | 2-8°C |
| 6-Chloro-9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine |
| 9H-Purine, 6-chloro-9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)- |